CYTOKINETICS INC - COMMON STOCK (CYTK)

Historical Holders from Q1 2014 to Q3 2025

Symbol
CYTK on Nasdaq
Type / Class
Equity / COMMON STOCK
Shares outstanding
119M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
141M
Holdings value
$7.74B
% of all portfolios
0.013%
Grand Portfolio weight change
+0%
Number of holders
376
Number of buys
222
Number of sells
-127
Average Value change %
+0%
Average buys %
+0.006%
Average sells %
-0.003%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of CYTOKINETICS INC - COMMON STOCK (CYTK)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
T. Rowe Price Investment Management, Inc. 16% +8.67% $1.05B $82.2M 19.1M +8.49% T. Rowe Price Investment Management, Inc. 30 Sep 2025
FMR LLC 10.9% +16.7% $480M $71.6M 13.1M +17.5% FMR LLC 31 Jul 2025
VANGUARD GROUP INC 10.09% $481M 11.9M The Vanguard Group 31 Dec 2024
STATE STREET CORP 4.7% $309M 5.62M STATE STREET CORPORATION 30 Sep 2025

Institutional Holders of CYTOKINETICS INC - COMMON STOCK (CYTK)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 141M $7.74B +$248M $54.96 376
2025 Q2 138M $4.55B +$22.8M $33.04 308
2025 Q1 135M $5.42B +$125M $40.19 352
2024 Q4 131M $6.18B -$305M $47.04 342
2024 Q3 136M $7.18B -$22.1M $52.80 343
2024 Q2 136M $7.34B +$905M $54.18 341
2024 Q1 118M $8.25B +$191M $70.11 385
2023 Q4 114M $9.54B +$330M $83.49 344
2023 Q3 109M $3.22B +$24.8M $29.46 248
2023 Q2 109M $3.55B -$11.5M $32.62 252
2023 Q1 109M $3.83B +$81.4M $35.19 259
2022 Q4 107M $4.88B +$56.1M $45.82 271
2022 Q3 105M $5.08B -$48.3M $48.45 271
2022 Q2 106M $4.16B +$425M $39.29 255
2022 Q1 95.5M $3.52B +$154M $36.81 233
2021 Q4 91.3M $4.16B +$41.3M $45.58 244
2021 Q3 90.2M $3.22B +$497M $35.74 208
2021 Q2 75.5M $1.49B +$7.26M $19.79 184
2021 Q1 74.8M $1.74B +$58.9M $23.26 185
2020 Q4 72.9M $1.52B +$2.99M $20.78 174
2020 Q3 68.8M $1.49B +$224M $21.65 176
2020 Q2 57.9M $1.36B +$106M $23.57 155
2020 Q1 55.6M $655M +$7.49M $11.79 140
2019 Q4 55M $583M +$111M $10.61 138
2019 Q3 44.5M $506M +$8.12M $11.38 142
2019 Q2 43.8M $492M +$60.8M $11.25 131
2019 Q1 39.1M $317M +$2.58M $8.09 128
2018 Q4 39.8M $251M +$585K $6.32 125
2018 Q3 38.6M $380M +$12M $9.85 115
2018 Q2 37.5M $311M +$6.02M $8.30 122
2018 Q1 36.8M $265M -$12.3M $7.20 120
2017 Q4 38.4M $313M -$31.8M $8.15 127
2017 Q3 39.5M $573M +$22.3M $14.50 128
2017 Q2 38.2M $463M +$120M $12.10 135
2017 Q1 28.3M $364M +$63.5M $12.85 105
2016 Q4 26.4M $321M -$2.24M $12.15 99
2016 Q3 26.7M $245M +$491K $9.18 88
2016 Q2 26.5M $252M +$5.26M $9.49 93
2016 Q1 26.6M $188M -$4.72M $7.05 105
2015 Q4 26.5M $277M +$56M $10.46 124
2015 Q3 21.6M $145M +$5.04M $6.69 102
2015 Q2 20.8M $139M +$7.72M $6.72 96
2015 Q1 19.6M $133M +$957K $6.78 92
2014 Q4 19.3M $155M +$202K $8.01 84
2014 Q3 19.8M $69.7M -$7.58M $3.52 82
2014 Q2 21M $101M -$36.4M $4.78 84
2014 Q1 22.5M $214M +$39.2M $9.50 104